FIELD: medicine, pharmaceutics.
SUBSTANCE: declared invention refers to chemical-pharmaceutical industry, and concerns a oral dosage form protected from unintended use with controlled release (1R, 2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol taken a day which contains specified active substance and/or one or more its pharmaceutically acceptable salts (A), at least one synthetic or natural polymer (C), an adjuvant delaying release of the active substance, other optional physiologically compatible adjuvants (B) exhibiting fracture strength at least 500 H. Besides such dosage can contain one of the listed ingredients preventing its unintended use (a) - (f): (a) at least one substance stimulate nasal or pharyngeal cavity, (b) at least one viscosity increasing agent, (c) at least one the active substance antagonist potentially being an object of its misuse, (d) at least one emetic, (e) at least one staining agent as an aversive agent, (f) at least one bitter substance.
EFFECT: development of the oral dosage form protected from unintended use with controlled release (1R, 2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol.
31 cl, 1 ex, 2 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
PROTECTED AGAINST UNADMINISTERED APPLICATION PERORAL MEDICATION FORM | 2005 |
|
RU2396944C2 |
MEDICINAL FORM PROTECTED AGAINST NON-INTENDED USE | 2004 |
|
RU2354357C2 |
DRUG DOSAGE FORM, PROTECTED FROM UNINTENDED APPLICATION | 2004 |
|
RU2339365C2 |
DEGRADATION-RESISTANT DOSAGE FORM WITH DELAYED RELEASE OF OXYCODONE HYDROCHLORIDE | 2010 |
|
RU2461381C2 |
COMPOSITION FOR THE TREATMENT OF VEISALGIA | 2017 |
|
RU2757379C2 |
PHARMACEUTICAL COMPOSITIONS | 2007 |
|
RU2445077C2 |
EXTENDED RELEASE DURABLE DOSAGE FORMS | 2006 |
|
RU2399371C2 |
MEDICINE CONTAINING 3-(3-DIMETHYLAMINE-1-ETHYL-2-METHYLPROPYL) PHENOL WITH PROLONGED RELEASE OF REACTANT | 2002 |
|
RU2325905C2 |
ABUSE-RESISTANT PHARMACEUTICAL COMPOSITIONS | 2015 |
|
RU2764569C2 |
REPOSITORY DOSAGE FORM CONTAINING 3-(2-DIMETHYLAMINOMETHYLCYCLOHEXYL)PHENOL | 2006 |
|
RU2445081C2 |
Authors
Dates
2010-07-10—Published
2005-06-29—Filed